Prostate Cancer Dream Team Members develop “classifier” to aid diagnosis - Stand Up To Cancer

Give Now

News

Prostate Cancer Dream Team Members develop “classifier” to aid diagnosis

Scientists with the SU2C-Prostate Cancer Foundation Dream Team have developed a “molecular classifier” for patients with metastatic prostate cancer that has become resistant to the standard hormone treatment.  Based on biomarkers, the “classifier” can help identify tumors that are transitioning to a more dangerous form of the disease, potentially improving treatment and benefitting the patient.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.